Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

BACKGROUND, AIM, AND METHODS—Alpha interferon is the generally approved therapy for HBe antigen positive patients with chronic hepatitis B, but its efficacy is limited. Lamivudine is a new oral nucleoside analogue which potently inhibits hepatitis B virus (HBV) DNA replication. To investigate the po...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schalm, S, Heathcote, J, Cianciara, J, Farrell, G, Sherman, M, Willems, B, Dhillon, A, Moorat, A, Barber, J, Gray, D, International, L
Formato: Artigo
Idioma:Inglês
Publicado em: 2000
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1727894/
https://ncbi.nlm.nih.gov/pubmed/10716688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.46.4.562
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados